Alerts will be sent to your verified email
Verify Email
MEDIORG
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Medicamen Organics is engaged in developing, manufacturing and distribution of broad range of pharmaceutical dosage including generic dosage in form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders for government (including both state and central governments) and private institutions as contract manufacturer / third party manufacturer.
Medicamen Organics major competitors are Shanmuga Hospital, Walpar Nutritions, Roopa Industries, Deccan Health Care, Sandu Pharmaceutical, Bacil Pharma, Shelter Pharma.
Market Cap of Medicamen Organics is ₹49 Crs.
While the median market cap of its peers are ₹50 Crs.
Medicamen Organics seems to be less financially stable compared to its competitors.
Altman Z score of Medicamen Organics is 2.66 and is ranked 6 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | ||||||||||||||||||
| Investor Presentation | ||||||||||||||||||
| Conference Call | ||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
